Asensus Surgical Inc (ASXC)
0.2215
-0.01
(-3.78%)
USD |
NYAM |
May 31, 16:00
0.2234
0.00 (0.00%)
After-Hours: 20:00
Asensus Surgical SG&A Expense (Annual): 36.08M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 36.08M |
| December 31, 2022 | 34.93M |
| December 31, 2021 | 32.72M |
| December 31, 2020 | 27.20M |
| December 31, 2019 | 46.77M |
| December 31, 2018 | 39.59M |
| December 31, 2017 | 29.81M |
| December 31, 2016 | 19.96M |
| December 31, 2015 | 10.69M |
| December 31, 2014 | 7.468M |
| December 31, 2013 | 5.664M |
| December 31, 2012 | 6.486M |
| December 31, 2011 | 2.306M |
| December 31, 2010 | 2.617M |
| December 31, 2009 | 1.399M |
| December 31, 2008 | 1.652M |
| December 31, 2007 | 1.135M |
| Date | Value |
|---|---|
| December 31, 2006 | 0.34M |
| December 31, 2005 | 0.318M |
| December 31, 2004 | 0.473M |
| December 31, 2003 | 1.118M |
| December 31, 2002 | 2.403M |
| December 31, 2001 | 3.158M |
| December 31, 2000 | 3.436M |
| December 31, 1999 | 2.80M |
| December 31, 1998 | 3.50M |
| December 31, 1997 | 8.20M |
| December 31, 1996 | 6.40M |
| December 31, 1995 | 4.20M |
| December 31, 1994 | 4.70M |
| December 31, 1993 | 3.60M |
| December 31, 1992 | 3.50M |
| December 31, 1991 | 2.40M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
27.20M
Minimum
2020
46.77M
Maximum
2019
35.54M
Average
34.93M
Median
2022
SG&A Expense (Annual) Benchmarks
| Glaukos Corp | 224.07M |
| Perspective Therapeutics Inc | 21.06M |
| Retractable Technologies Inc | 20.01M |
| Xtant Medical Holdings Inc | 64.29M |
| Catheter Precision Inc | 17.12M |